ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

July 11, 2014

NCCN, ACS Offer Publication For Patients About Nausea.

June 22, 2001

No Constitutional Right To Experimental Drugs, Appeals Court Rules Against Abigail Alliance.

August 10, 2007

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998

Avon, NABCO Accepting Grant Applications For Community-Based Breast Cancer Programs

June 9, 1995